Who are アルファフュージョン's investors?

アルファフュージョン's investors include Global Brain, Kobe University Capital, OSAKA University Venture Capital.

アルファフュージョン

3 known investors

Alpha Fusion is a Japanese biotechnology company developing targeted alpha therapy drugs based on Astatine-211 (211At) to treat cancer with reduced side effects to healthy tissue.

BiotechDigital Health

Investors · 3

Global BrainTokyo · $100K – $184M

Kobe University CapitalKobe

OSAKA University Venture CapitalOsaka · $3M – $142M

Competitors · 1

by search overlap

Alpha Ring3 shared keywordsAlpha Ring develops micro-fusion systems, including a tabletop fusion education device (Alpha-E), an aneutronic proton-boron fusion energy reactor (Alpha-F), and a medical ion beam system for Boron Neutron Capture Therapy (Alpha-M). It targets research institutions, industrial energy applications, and healthcare in the clean energy and nuclear fusion sector.

Companies competing with アルファフュージョン for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does アルファフュージョン do?: Alpha Fusion is a Japanese biotechnology company developing targeted alpha therapy drugs based on Astatine-211 (211At) to treat cancer with reduced side effects to healthy tissue.
Who are アルファフュージョン's investors?: アルファフュージョン's investors include Global Brain, Kobe University Capital, OSAKA University Venture Capital.